Microbiologic characterization and Antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 827-831

  Campbell, James I ^a,b,c,d   Yen, Lam Thi Minh ^a,b,c,d   Loan, Huynh Thi ^a,b,c,d   Diep, To So ^a,b,c,d   Nga, Tran Thi Thu ^a,b,c,d   Van Minh Hoang, Nguyen ^a,b,c,d   Son, Le Thanh ^a,b,c,d   Van Vinh Chau, Nguyen ^a,b,c,d   Parry, Christopher ^a,b,c,d   Farrar, Jeremy J ^a,b,c,d   Hien, Tran Tinh ^a,b,c,d   Baker, Stephen ^a,b,c,d  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; METRONIDAZOLE; NEUROTOXIN; OFLOXACIN; PENICILLIN G; TETANUS ANTIBODY; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CLINICAL EVALUATION; CLOSTRIDIUM TETANI; DEBRIDEMENT; DISEASE SEVERITY; DISK DIFFUSION; EPSILOMETER TEST; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TETANUS; TREATMENT DURATION; WOUND; DRUG EFFECT; INJURY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; VIET NAM; WOUND INFECTION;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM TETANI;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CLOSTRIDIUM TETANI; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; TETANUS; VIETNAM; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 66149141808     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.827     Document Type: Article

References (21)

1. Thwaites CL, Yen LM, Nga NT, Parry J, Binh NT, Loan HT, Thuy TT, Bethell D, Parry CM, White NJ, Day NP, Farrar J J, 2004. Impact of improved vaccination programme and intensive care facilities on incidence and outcome of tetanus in southern Vietnam, 1993-2002. Trans R Soc Trop Med Hyg 98: 671-677.
2. Dietz V Milstien JB, van Loon F, Cochi S, Bennett J, 1996. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ 74: 619-628.
3. Whitman C, Belgharbi L, Gasse F. Torel C, Mattei V, Zoffmann H, 1992. Progress towards the global elimination of neonatal teta-nus. World Health Stat Q 45: 248-256.
4. Udwadia FE, 1994. Tetanus. Oxford: Oxford University Press.
5. Wilkins CA, Richter MB, Hobbs WB, Whitcomb M, Bergh N, Carstens J, 1988. Occurrence of Clostridium tetani in soil and horses. S Afr Med. J 73: 718-720.
6. Mellanby J, Green J, 1981. How does tetanus toxin act? Neuroscience 6: 281-300.
7. Cook TM, Protheroc RT, Handel JM, 2001. Tetanus: a review of the literature. Br J Anaesth 87: 411-487.
8. Farrar JJ, Yen LM, Cook T, Fairweather N, Binh N, Parry J, Parry CM, 2000. Tetanus. J Neurol Neurosurg Psychiatry 69: 292-301.
9. Fairweather NF, Lyness VA, 1986. The complete nucleotide sequence of tetanus toxin. Nucleic Acids Res 14: 7809-7812.
10. Fairweather NF, Lyness VA, Pickard DJ, Allen G, Thomson RO, 1986. Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli. J Bacterial 165: 21-27.
11. Bruggemann H, Baumer S, Fricke WF, Wiezer A, Liesegang H, Decker I, Herzberg C, Martinez-Arias R, Merkl R, Henne A, Gottschalk G, 2003. The genome sequence of Clostridium tet-ani, the causative agent of tetanus disease. Proc Natl Acad Sci USA 100:1316-1321.
12. Campbell J, Farrar J, 2002. Antimicrobial Therapy and Vaccines. Volume 1, Microbes. New York: Appletrees Productions.
13. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, 1995. Manual of Clinical Microbiology, Sixth Edition. Washington, DC: ASM Press.
14. Hatheway CL, 1990. Toxigenic Clostridia. J Micro Rev 3: 66-98.
15. Clinical and Laboratory Standards Institute, 2007. Performance standards for antimicrobial susceptibility testing; 17th informa-tional supplement. MS100-S17. CLSI, Wayne, PA.
16. Nagao K, Mori T, Sawada C, Sasakawa C, Kanezaki Y, 2007. Detection of the tetanus toxin gene by polymerase chain reac-tion: a case study. Jpn J Infect Dis 60:149-150.
17. Bruggemann H, 2005. Genomics of clostridial pathogens: implica-tion of extrachromosomal elements in pathogenicity. Curr Opin Microbiol 8: 601-605.
18. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J, 2006. The multidrug-resistant human pathogen Clostridium dif-ficile has a highly mobile, mosaic genome. Nat Genet 38:779-786.
19. Ganesh Kumar AV, Kothari VM, Krishnan A, Karnad DR, 2004. Benzathine penicillin, metronidazole and benzyl penicillin in the treatment of tetanus: a randomized, controlled trial. Ann Trop Med Parasitol 98: 59-63.
20. Thwaites CL, Farrar JJ, 2003. Preventing and treating tetanus. BMJ 326:117-118.
21. Kabura L, Ilibagiza D, Menten J, Van den Ende J, 2006. Intrathecal vs. intramuscular administration of human antitetanus immu-noglobulin or equine tetanus antitoxin in the treatment of teta-nus: a meta-analysis. Trop Med Int Health 11: 1075-1081.